{"name":"Tarsier Pharma","slug":"tarsier-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOTS1YWlVUcFFiZ016a0xISXJTVU43dV81T01GN2hiTTVqWFFfeU1VM09CcWFKbl9sWk9OWkdNa3I1M1NoQ0F5OEdBUlkyV0w2dVF1QlA2VERIWGstSFplQ19RTjlUZnFzaEZ0dHZXY2Q0SUVaZjRsWGdqUzVTdWM5S2VobloxdmZTZ1JxRWVQNk9JVlhCa3h5NmJWNUJjVW1oMXJQY1BpbjB1ejVYeEJNQm1mcU4yVmxrQUMyeEo5Nl9ES0VKX1pNWk8tdVlzeWVwVEhLYjNLbTlkYW5GRUttTC1ZQllDbEtQUGptQUZNZ2NXVHBfenN5YjJXclhSMGN4LU5mTQ?oc=5","date":"2025-07-24","type":"trial","source":"PR Newswire","summary":"Tarsier Pharma: New Data Reveal Sharp Rise in Vision Loss from Uveitis, Underscoring Urgent Need for Safer Treatments - PR Newswire","headline":"Tarsier Pharma: New Data Reveal Sharp Rise in Vision Loss from Uveitis, Underscoring Urgent Need for Safer Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNVk15TEFJUGJEUUFtV21VaVNfLUc4WXljUGxvejY4UGlTUG1oQS1DeVdVVUtQSDh6MVpwSWJIRWRUWVctOTBNNGJ1MGs2Q3hLU3Q5TG1XS1Via0x4a3N3UU15VG5IX2pJM1ZYQU5CMTdLa1RsUEZrUG1xOFNYekd1bHJmMFkxeGpJT2M5ZXA2WjFPV0h2RjBIZnYzcVdPYzFqR0VpNHY2VmUxY21haHBF?oc=5","date":"2025-01-07","type":"pipeline","source":"Contract Pharma","summary":"Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer - Contract Pharma","headline":"Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQVFFULWNXQ3ZuTWtPR2JqR21wWkdKN0ozSExkNHJ5T2FZMWZMN2lkaVQ2S1JJTnhaeTd2Z0gwUGp0aDNweEtQLVV2TzhUTC1zVXRVeVVuM3FPQ2xiYmRxenphQ3B0MnE1cmFLS1hwTkxHTms5NmtxcU40aEdhWENhZ1R1X2hvenZMb0hYeWNVbzg0dzRTbi1JclZpMnpGR3h4Vk5LM1FpdzAyWmNVblZyRFRlUUlwc1psTlhtTzR0ZFQ1YW1SNENDSi1ZclB3ZHBybVBib0JEb25wdEJWQ1VzMVBRWQ?oc=5","date":"2025-01-07","type":"pipeline","source":"PR Newswire","summary":"Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence - PR Newswire","headline":"Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxObkRyc3F1S0JaRk1jN3d0dXVtZ1lCbDhCX1lBcUp6OTdfVXhFWFg3TVZwVTZXdGsxcDNHNURtdC1Pc3pENHdQMVNOMnlDN1BNcDE4eDRwQ3NucVNUS2Q1QW1NYUNidktPdXVYRklkM1dPdTZOd2lURXR4TTh4LURlX2VJSGZJR0tWaEplYVh4U05IN21IREJiUzRhOW43WTNqRXBzcEhBRFlXMllWYnROdE9HNUM0YUNKOE1ZQUEtUDFOMjI0TFlhQ01VM0luS1hoWDlwODdOTQ?oc=5","date":"2024-01-18","type":"regulatory","source":"Ophthalmology Times","summary":"Tarsier Pharma receives FDA agreement under Special Protocol Assessment for Tarsier-04 Phase 3 Trial - Ophthalmology Times","headline":"Tarsier Pharma receives FDA agreement under Special Protocol Assessment for Tarsier-04 Phase 3 Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNNUppdF9RX1NySVFLSjNxT0E2WHI3Nk9TTFNla2E1d2FCSS1wWktBbEVIdW8ycG9WbmFSZjVNTktlYWxKcU5yTGZsekFwZHJ3VFhvblVkUmkwN3k5SUg2SFZBMzlqZHdIOThNNllXZlV4ZXhYanZZcFRpR3N5YUx6VmtQbmJjMU84eVpOMVg1d2s0akloUmh3TA?oc=5","date":"2024-01-16","type":"regulatory","source":"HCPLive","summary":"FDA, Tarsier Pharma Reach Agreement on Phase 3 Trial of TRS01 Eye Drops - HCPLive","headline":"FDA, Tarsier Pharma Reach Agreement on Phase 3 Trial of TRS01 Eye Drops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxNTklDQzZxdGFqQUZTVGIwTEpTYlhOWGE2WFFCaTFDRnZMQ0luT0RfbzI1aGZ3NzR6NkN0aHVGUTdUTFBJbkFMdlB6Y2lITW5OVWRGUi1WSUFuWGt6SnkyeFRvLXJfcGQwelNBMnRjaTc4b0ozLVB5elk2TWQtYzV5MW5HNXhyNDk3QUNhSWozTTg3TG1lVXc3eDBkRks3RFBCbXcyRndCS2dUaXZRTnF2UDJBSjN3UVV6Q1I3Uk1CZ3RaVXBST3NQUTRYemFCT1lwVzlMSm56MlFWYTZZY3FFUXZyNV9ibURCSXlKSnNIdjdHel9MRkt2QUZyTEw2d3VpcGFKMHdiMEZTMHlxNG1iZEFnaGdDQkw1NUt0RUVVUVlyNy1IVVk1S19YbzMzUzVkQi1sbHpScDFmd2tXRWN0MTljRWtnVm9ZdUFBOVpn?oc=5","date":"2024-01-16","type":"regulatory","source":"BioSpace","summary":"Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Ophthalmic Solution for the Treatment of Non-infectious Uveitis including Uveitic Gl","headline":"Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Opht","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMElCeFlKdFliOHRNUWRNcXRuZmdPNlEwcHp6dnc0T2pSMW5TNjZYTEpMY2FxRktoMVpWZ0pkSF9MU0g4eHY4OXVwYVhfSFI0U25nRXhMeVhFaGtGekZlUG5WSDlqbTI0Tmxxd3htWDI1U1BiUzJZamdJMlVrUjU3djFERHROWkQ2V2pfYWpGQkMtMXl4RGZEWFRPckF4UWlKVFlsUktPV3JJRENZVkYybEtGY1lmaG5UTUF3?oc=5","date":"2023-11-14","type":"regulatory","source":"Ophthalmology Times","summary":"Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis - Ophthalmology Times","headline":"Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNOTFoZ0JveDFzbnpQR2FxbkFXbnlnb2ZzRnNoQ2JOZmwtaWpXdjk1aE9TTWQ2dFRLbnZaWFo1WWxIc3pJcTZkSVlWUjl5X2VwVkhSQ1BLbXctTnFhc2lsU25IVGJOZWxyN0FuX0FIZVkzUXRuVjlTazFEOUw0ZHY1LWxoOGdpQ01pc3JCcldyQ2NvVkxqek8wcXNGSEJuSHBi?oc=5","date":"2023-08-24","type":"trial","source":"Ophthalmology Times","summary":"Tarsier Pharma shares results from phase 3 TRS4VISION trial - Ophthalmology Times","headline":"Tarsier Pharma shares results from phase 3 TRS4VISION trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQRzhXRkNpYllBMzNNaHI5ZUZ5bmdicnExdWhfOWdYc2h0TGkxb0g5NFowVkpVSUV6Mm1UaThoUDlqRm84Z1o1cmtIYmRYb0M0UFV0OXhQRWdTeWdWN2Q2Y2Q4d0hFYjdLUkFUZk1hV3l6X2VXc0dEUlBCQ3dGZV9yV0ZWWDVKZ29vOFE?oc=5","date":"2023-08-24","type":"regulatory","source":"Clinical Trials Arena","summary":"Tarsier fails to meet primary endpoint in TRS01 trial, seeks to consult FDA - Clinical Trials Arena","headline":"Tarsier fails to meet primary endpoint in TRS01 trial, seeks to consult FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPOFVHVGM3TkswRGo0WWZBZzhKUV9QWV9VZVdSczBCVVI2SktYaEo3V0JFc2d3UFN6VWNsRERmbEdnNzJXU3AwWDdKd2stRDkxR3hOQW1UWG5aMnZUMVF3Y0pvUkNUNzdVdmZsZEd4dDFBYzZWYjUzRmJNNzhfT3ZIOXI1clhqRWE5Mk51NXFNZ1ZfbHI1cTVSV1JMdXEzWExxVmdIazNNTVRiTERPc18zYWU2d1h3UmZPMkJqa01JZWFkZmFJUDRNTmhTQ2JBSnlueEdJblRvRHJhUFVwTlZCaENiSVFjajdlcHl0dWdnUmNYZHVfWjI3QnA3aTFWRm1sSFlubU51SQ?oc=5","date":"2023-08-23","type":"trial","source":"BioSpace","summary":"Tarsier Pharma Announces Results from a Phase 3 Clinical trial in Subjects with Noninfectious Anterior Uveitis Including Subjects with Uveitic Glaucoma - BioSpace","headline":"Tarsier Pharma Announces Results from a Phase 3 Clinical trial in Subjects with Noninfectious Anterior Uveitis Including","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNUThrbUdKS2QxejhiMnNwTTBicnBQV2R2T1BJYlNldDNSYXRtSXQ3SURlN1pKaGpjVlhKNnczU0xlaGRHTV8yd1QwMm9CbmROV2tlWm1FYTZFLXpldG9DNzI0VFQtNHJHbUNqWi1mdGVTdVJVR0d5RURrU0ljQjM1ajk3R2tOQ1VuSW1EMG11UmQ3NFJkZ09sQlVTdWVrWnBEVjhJTTU0Z0FYUFkzdllSQXNtc2NseWhuT1hqR3FzTGI1blRzTzJSOHhCd2kzYVhPdXVUOWtkNk1xampNYW1rRXZubTRDZw?oc=5","date":"2021-11-30","type":"pipeline","source":"PR Newswire","summary":"Tarsier's CEO and Founder, Dr. Daphne Haim Langford, wins the 2021 EU Prize for Women Innovators - PR Newswire","headline":"Tarsier's CEO and Founder, Dr. Daphne Haim Langford, wins the 2021 EU Prize for Women Innovators","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPNUlITW1oZlBEQlFrUzA4UV9DUEhRU0JtcFFadzJRSVQ2Y2lUQ05fVlBYY05iRm9kdUN2QXdkY0NVMHR1ZHJTcVV0SjlEeTBWNzNmeUc4cy1uVEszRUM5dWlLUU9weTFBN3dNQldjemlCdXNmQW1MNlNVY0J3RTl0NjI4NFRQc0dQeU9CVUxER3pSOXp2MzhIZ1JSLUNQQk9UWUVzd3E3V2tzTzJKdlpjMGZMZmZtMnJfSF9FUDhvY1c3WHJwUjJv?oc=5","date":"2021-04-27","type":"regulatory","source":"www.israelhayom.com","summary":"Tarsier Pharma’s bio treatment for blinding ocular disease receives ‘positive’ FDA feedback - www.israelhayom.com","headline":"Tarsier Pharma’s bio treatment for blinding ocular disease receives ‘positive’ FDA feedback","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}